These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30134292)

  • 1. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
    Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
    Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
    Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
    AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa.
    le Roux SM; Donald KA; Brittain K; Phillips TK; Zerbe A; Nguyen KK; Strandvik A; Kroon M; Abrams EJ; Myer L
    AIDS; 2018 Aug; 32(13):1781-1791. PubMed ID: 29794831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcomes in young children born to HIV-positive mothers in rural Yunnan, China.
    Wu J; Li J; Li Y; Loo KK; Yang H; Wang Q; Duan R; Xiao X; Song X; Yang S; Sun L
    Pediatr Int; 2018 Jul; 60(7):618-625. PubMed ID: 29663621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.
    Kacanek D; Williams PL; Mayondi G; Holding P; Leidner J; Moabi K; Tepper V; Nichols S; Makhema J; Jibril H; Madidimalo T; Shapiro R; Lockman S; Kammerer B
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):e93-e100. PubMed ID: 30015793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa.
    Madlala HP; Myer L; Malaba TR; Newell ML
    PLoS One; 2020; 15(11):e0242244. PubMed ID: 33206724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
    Desmonde S; Goetghebuer T; Thorne C; Leroy V
    Curr Opin HIV AIDS; 2016 Sep; 11(5):465-476. PubMed ID: 27716731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
    Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
    Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental outcomes in HIV-infected and uninfected African children.
    Debeaudrap P; Bodeau-Livinec F; Pasquier E; Germanaud D; Ndiang ST; Nlend AN; Ndongo FA; Guemkam G; Penda CI; Warszawski J; Koecher D; Faye A; Tejiokem MC;
    AIDS; 2018 Nov; 32(18):2749-2757. PubMed ID: 30289800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preterm Birth and Antiretroviral Exposure in Infants HIV-exposed Uninfected.
    Piske M; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen PA; Money DM; Côté HCF;
    Pediatr Infect Dis J; 2021 Mar; 40(3):245-250. PubMed ID: 33480662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.